AiCure Named to the 2018 AI 100, Highlighting Advancements in Artificial Intelligence for Patient Monitoring

SAN FRANCISCODec. 12, 2017 /PRNewswire/ — CB Insights today named AiCure to the prestigious AI 100, a select group of promising private companies working on groundbreaking artificial intelligence technology. CB Insights CEO and co-founder Anand Sanwal will reveal the full list of the second annual AI 100 companies at the A-ha! conference in San Francisco.

“Last year’s AI 100 enjoyed amazing success in the year since earning this recognition. 55 of them went onto raise additional funding nearing $2B and 5 were acquired.

This year’s list was culled from 1000+ applications and looks even more impressive.  These are companies using artificial intelligence in industries from drug discovery and cybersecurity to robotics and legal tech.  I’m happy that CB Insights is able to shine a light on the founders and companies that will revolutionize these industries and look forward to seeing what they do in 2018 and beyond.” said CB Insights CEO Anand Sanwal.

Adam Hanina, co-founder and CEO of AiCure, commented: “We are delighted to be recognized as one of the world’s 100 most innovative AI companies. AiCure is tackling the multibillion dollar problem of failed trials and poor clinical outcomes. Our visual recognition platform is creating enormous impact and value through intelligent observation.”

The CB Insights research team selected the AI 100 companies based on criteria, examining company-submitted data and the company’s Mosaic Score. The Mosaic Score, based on CB Insights’ National Science Foundation-funded algorithm, measures the overall health and growth potential of private companies. Through this evidence-based, statistically-driven approach, the Mosaic Score can help predict a company’s momentum, market health and financial viability.

Companies such as Flatiron Health, Babylon, and Freenome joined AiCure in being recognized for their innovative technology in front of an audience of 400 senior innovation executives from around the world and news outlets including The Financial Times, CNBC, Reuters, Bloomberg and the Washington Post.

About AiCure
AiCure’s intelligent medical assistant, IMA, leverages a visual recognition platform to monitor patient progress. IMA provides visual dose confirmation, interactive patient support and engagement, and visual diagnostic capabilities. With almost 100 patents awarded or pending and funding from leading institutional investors and the National Institutes of Health, the platform has been validated to improve patient behavior in randomized controlled trials. AiCure is revolutionizing drug development and clinical care by ensuring that high quality treatments reach the patients that need them most. Intelligent observation leads to better care.

For more information contact:
Press Officer
AiCure
press@aicure.com
800-570-0448

Quick facts on the AI 100:

  • These 100 emerging private companies have raised $6.6B across 99 deals in 2017.
  • Applications of their technology include breakthroughs in fintech, digital health, auto tech, robotics, and much more.
  • More than 1,000 companies were nominated or applied and only 9% were selected.
  • Eleven AI 100 companies have reached a valuation of $1B or more.
  • Thirty-three companies on the list were also on the list for 2017, with 67 new companies making it for 2018.
  • Nine countries are represented among the AI 100 companies.

The AI 100 Companies (in alphabetical order):

AEYE

CrowdFlower

Liulishuo

SenseTime

Affirm

CrowdStrike

MAANA

Shape Security

Afiniti

Cybereason

Merlon Intelligence

Sher.pa

AiCure

Darktrace

Mighty AI

Shield AI

Algolia

DataRobot

Mobalytics

Shift Technology

Amplero

Deep Sentinel

Mobvoi

Socure

Anki

Descartes Labs

MOOGsoft

SoundHound

Appier

Drive.ai

Mya Systems

SparkCognition

Applitools

Dynamic Yield

Mythic

Sportlogiq

Appthority

Element AI

Narrative Science

Tamr

Aquifi

Endgame

NAUTO

Tempus Labs

Arterys

Face++

Neurala

Text IQ

babylon

Flatiron Health

Numerai

Textio

Benson Hill Biosystems

FLYR

Obsidian Security

Tractable

Brain Corporation

Foghorn Systems

Onfido

Trifacta

Bytedance

Freenome

Orbital Insight

Twiggle

C3 IoT

Gong

OrCam Technologies

UBTECH Robotics

Cambricon

Graphcore

Osmo

Upstart

Cape Analytics

InsideSales.com

PerimeterX

Versive

Captricity

Insight Engines

Petuum

Vicarious Systems

Casetext

Insilico Medicine

Preferred Networks

Workey

Cerebras Systems

Invoca

Primer

WorkFusion

CloudMinds

Kindred Systems

Prospera

ZestFinance

CognitiveScale

KYNDI

Recursion Pharmaceuticals

Zoox

Conversica

LeapMind

Reflektion

Zymergen

About CB Insights
Our team builds technology that helps corporations guess less and win more. We aggregate and analyze terabytes of data and use machine learning, algorithms and data visualization to help corporations replace the three Gs (Google searches, gut instinct and guys with MBAs*) so they can answer massive strategic questions using probability not punditry.

*We have MBAs.

Contact:
Farrah Kim, Senior Public Relations & Communications Manager
fkim@cbinsights.com
212-292-3148

For more information about the AI 100, visit:
https://www.cbinsights.com/research-ai100

To learn more about A-ha!, go here: http://events.cbinsights.com/aha

 

SOURCE AiCure

Related Links

http://www.aicure.com

Connect with AiCure:

About AiCure

AiCure’s artificial intelligence visually confirms medication ingestion on any smartphone. The clinically-validated platform enables continuous monitoring and intervention for greater statistical power and sample size reductions in clinical trials and improved health outcomes in population health. AiCure has developed an extensive intellectual property portfolio and been funded by the National Institutes of Health and leading institutional investors. For more information, please visit www.aicure.com

Corporate Inquiries:

Stefanie Kuhner
Head of Corporate Development
stefanie.kuhner@aicure.com
646-891-9422

Media contact:

  • Press Officer
  • AiCure
  • press@aicure.com
  • 800-570-0448

Complete the form below to download

Fields marked with * are mandatory

+

Contact AiCure to learn more

Fields marked with * are mandatory








+